Tarsons Products Share Price Target 2026 Analyst Forecast Bull and Bear Case
- June 24, 2026
- Posted by: Kunal Singla
- Category: News
The Tarsons Products share price target 2026 is Rs 315, implying approximately 20 percent upside from the current market price of Rs 263.07 (NSE: TARSONS). With Q4 FY26 results released in 2026 and Laboratory Plasticware and Life Sciences tailwinds in focus, the Rs 315 price objective is supported by the FY27 earnings recovery thesis.
Tarsons Products (NSE: TARSONS) is a Laboratory Plasticware and Life Sciences company trading at Rs 263.07 with a market capitalisation of Rs 1,581 crore. Analysts have set the Tarsons Products share price target at Rs 315 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast including sector tailwinds, key risks, and bull and bear scenarios.
Click Here – Get Free Investment Predictions
Tarsons Products Share Price Target 2026: Key Takeaways
- Tarsons Products share price target 2026: Rs 315 (20% upside from CMP Rs 263.07)
- Bull case: Rs 380 | Bear case: Rs 210
- Ticker: TARSONS | Sector: Laboratory Plasticware and Life Sciences | MCap: Rs 1,581 crore
- 52W range: Rs 182 to Rs 432 | PE: 25x
- Key catalyst: Q4 FY26 results and FY27 earnings confirmation in 2026
- Key risk: FY27 earnings miss or FII outflows from Indian equities
Tarsons Products Company Overview
Tarsons Products (NSE: TARSONS) is a Kolkata-based manufacturer of precision laboratory plasticware, consumables, and scientific instruments for research laboratories, hospitals, and pharmaceutical quality testing. At CMP Rs 263.07 against a 52 week range of Rs 182 to Rs 432, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 1,581 crore with trailing PE of 25x. Compared to peers in lab supplies like Borosil and Himedia Laboratories, Tarsons Products is positioned as a potential re-rating candidate toward the Rs 315 price objective on FY27 earnings delivery.
| Parameter | Value |
|---|---|
| NSE Ticker | TARSONS |
| Sector | Laboratory Plasticware and Life Sciences |
| CMP (2026) | Rs 263.07 |
| 52 Week High | Rs 432 |
| 52 Week Low | Rs 182 |
| Market Cap | Rs 1,581 crore |
| Trailing PE | 25x |
| 12-Month Analyst Target | Rs 315 |
| Bull Case Target | Rs 380 |
| Bear Case Target | Rs 210 |
Why Is the Tarsons Products Share Price Target Set at Rs 315 for 2026
FY27 Earnings Recovery and Revenue Acceleration
The Tarsons Products share price target of Rs 315 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for re-rating from CMP Rs 263.07.
Structural Sector Tailwinds in Laboratory Plasticware and Life Sciences
The Laboratory Plasticware and Life Sciences sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Tarsons Products’s position among peers in lab supplies like Borosil and Himedia Laboratories creates a structural growth runway. Sustained outperformance is one of the key conditions for the Rs 380 bull case to materialise.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s RBI rate cut cycle in 2026 is reducing borrowing costs and stimulating end market demand. Lower interest costs improve Tarsons Products’s EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 315 analyst consensus.
Union Budget 2026-27 Capex Push and Policy Support
Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex and PLI scheme continuity create a favourable backdrop for Tarsons Products’s Laboratory Plasticware and Life Sciences operations, improving the probability of achieving the Rs 315 price objective through FY27 earnings delivery.
FII Flow Normalisation After the 2026 Tariff Shock
As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 25x PE, Tarsons Products is positioned as a beneficiary of institutional reallocation toward the Rs 380 bull case over the medium term.
Tarsons Products Share Price Targets: Short Term, 12 Month, and Long Term
Short Term Tarsons Products Share Price Target
Near-term support for Tarsons Products is anchored close to the 52 week low of Rs 182. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating from CMP Rs 263.07.
12-Month Tarsons Products Share Price Target 2026
The 12-month Tarsons Products share price target 2026 is Rs 315, implying approximately 20 percent upside from CMP Rs 263.07. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows.
Long Term Tarsons Products Share Price Target: FY27 to FY28
The long term Tarsons Products share price target for FY27 to FY28 is Rs 380 in the bull case, requiring full earnings delivery, re-rating among peers in lab supplies like Borosil and Himedia Laboratories, and sustained institutional buying over a 2 to 3 year horizon.
Bull Case and Bear Case Scenarios for Tarsons Products in 2026
Bull Case Tarsons Products Share Price Target: Rs 380
The bull case Tarsons Products share price target of Rs 380 materialises when FY27 earnings beat analyst estimates, Laboratory Plasticware and Life Sciences tailwinds accelerate, and FII flows return strongly to Indian equities. From CMP Rs 263.07, this represents approximately 45 percent potential upside.
Bear Case Tarsons Products Share Price Target: Rs 210
The bear case Tarsons Products share price target of Rs 210 materialises if FY27 earnings disappoint or FII outflows depress the broader market, risking a test of support near the 52 week low of Rs 182.
| Scenario | Target | Key Conditions |
|---|---|---|
| Bull Case | Rs 380 | FY27 beat, sector re-rating, FII inflows |
| Base Case (Analyst Target) | Rs 315 | In-line FY27 delivery, partial FII recovery |
| Bear Case | Rs 210 | FY27 miss, guidance cut, FII outflows persist |
Key Risks That Could Derail the Tarsons Products 2026 Price Objective
Global Macro and US Tariff Headwinds
Prolonged tariff tensions and global demand slowdown remain prominent macro risks to the Tarsons Products share price target of Rs 315, with FII outflows being the direct transmission mechanism to Indian equity valuations.
FY27 Earnings Miss and Guidance Risk
An FY27 earnings miss or downward guidance revision would compress valuation multiples and is the most direct company-specific risk to the Rs 315 analyst price objective. Investors must monitor quarterly results and management commentary closely.
Competitive Intensity Among Laboratory Plasticware and Life Sciences Peers
Intensifying competition from peers in lab supplies like Borosil and Himedia Laboratories could compress Tarsons Products’s market share and pricing power, a structural risk that must be weighed when assessing the defensibility of the earnings trajectory underpinning the Rs 315 analyst target for 2026.
Liquidity Risk and FII Selling Pressure
Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. Investors should maintain position sizing discipline and stop losses to protect capital.
How to Invest in Tarsons Products
Check the Univest Screener for live data
Before considering any investment based on the Tarsons Products share price target of Rs 315, review Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, margin trends, and management commentary on Laboratory Plasticware and Life Sciences sector demand.
Open a Demat account with a SEBI registered stockbroker to trade Tarsons Products (NSE: TARSONS) with full regulatory protection. Study the competitive landscape among peers in lab supplies like Borosil and Himedia Laboratories before executing any position.
Plan your entry using the 52 week low of Rs 182 as a key support reference. A confirmed FY27 earnings uptick validates the entry case for the Rs 315 price objective. Always set a stop loss below the 52 week low.
Restrict any single stock to 3 to 5 percent of your total equity portfolio. Always consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to track Tarsons Products’s live share price and receive daily stock recommendations.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.
FAQs on Tarsons Products Share Price Target 2026
What is the Tarsons Products share price target for 2026?
Ans. The Tarsons Products share price target 2026 is Rs 315, implying approximately 20 percent upside from CMP Rs 263.07. Bull case is Rs 380, bear case is Rs 210.
What was the Tarsons Products share price target for 2025?
Ans. The 2025 price objective for Tarsons Products was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 315, reflecting FY27 growth potential from CMP Rs 263.07.
Is Tarsons Products a good investment at Rs 263.07?
Ans. At Rs 263.07, Tarsons Products offers potential upside toward Rs 315 if FY27 earnings recover. Whether this represents a good entry depends on individual risk tolerance. Consult a SEBI registered financial advisor before investing.
What are the key risks to the Tarsons Products share price target 2026?
Ans. Key risks to the Tarsons Products share price target of Rs 315 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Laboratory Plasticware and Life Sciences. Monitoring quarterly results is essential.
What is the 52 week high and low of Tarsons Products?
Ans. The 52 week high of Tarsons Products is Rs 432 and the 52 week low is Rs 182. At CMP Rs 263.07, the stock offers potential upside toward the Rs 315 price objective.
What are the main growth catalysts for Tarsons Products in 2026?
Ans. Key catalysts include FY27 PAT recovery, Laboratory Plasticware and Life Sciences tailwinds, RBI rate cuts in 2026, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.
How does Tarsons Products compare to its peers?
Ans. Tarsons Products operates in Laboratory Plasticware and Life Sciences alongside peers in lab supplies like Borosil and Himedia Laboratories. At CMP Rs 263.07 with MCap Rs 1,581 crore, it is a potential re-rating candidate toward the Tarsons Products share price target of Rs 315 on FY27 delivery.
What is the Tarsons Products share price target for 2027?
Ans. The long-term Tarsons Products share price target for FY27 to FY28 is Rs 380 in the bull case, assuming earnings growth, sector re-rating, and FII inflows. Consult a SEBI registered financial advisor for personalised guidance.
